Calumet, Inc. /DE Files 8-K Report

Ticker: CLMT · Form: 8-K · Filed: Feb 12, 2025 · CIK: 2013745

Calumet, INC. /De 8-K Filing Summary
FieldDetail
CompanyCalumet, INC. /De (CLMT)
Form Type8-K
Filed DateFeb 12, 2025
Risk Levellow
Pages2
Reading Time3 min
Key Dollar Amounts$0.01, $782 million
Sentimentneutral

Sentiment: neutral

Topics: 8-K, corporate-filing, disclosure

TL;DR

Calumet Inc. filed an 8-K on Feb 12, 2025, confirming HQ in Indianapolis.

AI Summary

On February 12, 2025, Calumet, Inc. /DE filed an 8-K report. The filing indicates the company's principal executive offices are located at 1060 N Capitol Ave, Suite 6-401, Indianapolis, Indiana, 46204. The report was filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

Why It Matters

This 8-K filing serves as a public notification of Calumet, Inc.'s official reporting status and provides key corporate contact and location information.

Risk Assessment

Risk Level: low — This filing is a routine corporate disclosure and does not contain information that inherently poses a significant risk.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this Form 8-K filing?

The primary purpose is to report current information as required by Section 13 or 15(d) of the Securities Exchange Act of 1934, specifically noting the date of the report and the company's principal executive offices.

When was this Form 8-K filed?

The Form 8-K was filed as of February 12, 2025.

Where are Calumet, Inc.'s principal executive offices located?

Calumet, Inc.'s principal executive offices are located at 1060 N Capitol Ave, Suite 6-401, Indianapolis, Indiana, 46204.

What is the company's state of incorporation?

The company's state of incorporation is Delaware.

What is the registrant's telephone number?

The registrant's telephone number, including area code, is (317) 328-5660.

Filing Stats: 654 words · 3 min read · ~2 pages · Grade level 13 · Accepted 2025-02-12 08:30:14

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CALUMET, INC. Date: February 12, 2025 By: /s/ David Lunin Name: David Lunin Title: Executive Vice President and Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing